this week

List

September 16th, 2011

Purchase Cipro

[This review was originally posted at the Nieman Journalism Lab Purchase Cipro, on Sept. 2, 2011.]

Hurricane news' innovation and hype: The big U.S. news story this week was Hurricane Irene, which hit the East Coast and New England last weekend. It was a story that hit particularly close to home for many of the U.S.' leading news organizations, which led to some innovative journalism, but also some questionable coverage, Cipro treatment, too.

Several news organizations temporarily took down their online paywalls during the storm, led by the New York Times and the Long Island newspaper Newsday. The Times also used the storm as an opportunity to introduce a new Twitter account devoted to curation of information on Twitter by the paper's editors, Purchase Cipro. The Lab's Megan Garber noted that the account is incorporating much more conversation than the Times' other official Twitter accounts, and Jeff Sonderman of Poynter talked to the Times about its goal with the account — to provide a space for faster, more unrestrained information from the Times on Twitter. Cipro street price, Another good example of storm-related news innovation: The Journal Register Co.'s Ben Franklin Project.

Irene was also a big occasion for TV news, which trotted out the usual round-the-clock coverage and on-location weather-defying reports. After the storm passed through, many questioned whether news organizations had gone over the top in their breathless coverage of Irene. The Daily Beast's Howard Kurtz accused cable news Purchase Cipro, of being "utterly swept away by the notion that Irene would turn out to be Armageddon," and at the Boston Herald, Michael Graham called the Irene coverage "a manufactured media product with a tenuous connection to the actual news."

Others (many outside the TV news industry) pushed back against those charges: Northeastern j-prof Dan Kennedy said that the storm's damage actually largely matched the coverage; it just seemed like it fizzled out because that damage wasn't near New York or Washington. The New York Times' Nate Silver took a more scientific approach and made a similar conclusion, showing that the amount of Irene coverage was generally in line with that of previous storms, when the level of damage was factored in, Cipro dose.

Poynter's Julie Moos, who put together a great summary of the hurricane hype debate, also argued that Irene's severity matched the level of coverage, providing along the way a useful six-part measuring stick for journalistic hype. "The perception of hype is fed by the gap between supply and demand," she said. "Journalists must make more closely calibrated decisions than ever about what information to provide."

—

Social network as identity service: Google CEO Eric Schmidt threw some more fuel onto the slow-burning argument over Google+ and real names when he said at a conference last weekend that the new social network is essentially an "identity service with a link structure around your friends" — a way for others on the Internet to verify your identity and communicate with you under that identity. Where can i cheapest Cipro online, Asked about the risks to some people of such a hard-and-fast online identity, Schmidt replied that, well, they don't have to use Google+ then.

It was quite a telling quote regarding Google+'s true purpose — one that several commentators seized on, Purchase Cipro. Mashable's Pete Cashmore described the battle between Google and Facebook over web identity and reasoned that the reason Google is taking a hard line on real names is that it needs its identity system to be more reliable than Facebook's. Venture capitalist Fred Wilson said now we officially know who the real-names policy is really for: Google, not us. "The answer to why you need to use your real name in the service is because they need you to," he said, where to buy Cipro.

GigaOM's Mathew Ingram used the statement to tie together his description of what's at stake in the identity competition — the more accurate and detailed identities are, the more advertisers will pay for them. Tech blogger Dave Winer was more blunt: Google+ is a bank, he said. Purchase Cipro, They need people's real names because they want to move money around, like any other business. At the Guardian, tech writer Cory Doctorow argued that we need to open up this discussion about online identity, Cipro class, and that the single-identity philosophy Google's espousing isn't in our best interests.

Meanwhile, this month's Carnival of Journalism blog ring wrote about Google+, with several writers urging journalists and academics to "just use it," as the University of Colorado's Steve Outing put it. Spot.Us' David Cohn put the rationale well: "The reason to be on Google+ isn’t because it’s the newest, hottest, sexiest thing, Cipro from canadian pharmacy. ... You should be on these sites to understand how people are communicating and the vocabulary of this communication."

—

CNN grabs Zite: Major news organizations have been itching to jump into the increasingly crowded market for tablet-based news readers, and this week CNN made its own play, snatching up Zite, the personalized, magazine-like iPad news app launched in March. All Things Digital's Kara Swisher put the purchase price between $20 million and $25 million and explained the simple reason for CNN's interest: They're trying to acquire the technology to keep up with audiences that are quickly moving onto mobile platforms for their news, Purchase Cipro.

Zite will continue to operate as a separate unit, Cipro long term, across the country from CNN's headquarters. According to mocoNews' Tom Krazit, CNN will help Zite scale up to a bigger audience, while Zite will work to improve CNN's mobile offerings. And when asked by Mashable's Lauren Indvik about adding ads, CNN execs said they're going to build up the product first and worry about the business model later. Mathew Ingram of GigaOM said Zite can help CNN learn what people are sharing, why, Cipro use, and how they want news presented in a mobile format.

—

WikiLeaks' inadvertent cable release Purchase Cipro, : This week marked what looks like the beginning of a new, bizarre confusing chapter in the WikiLeaks saga. The story's been a bit of a confusing story, but I'll try to break it down for you: Ever since last November, WikiLeaks has been gradually releasing documents from its collection of diplomatic cables. But over the past couple of weeks, the full archive of 251, Cheap Cipro no rx, 000 cables was inadvertently released online, without sensitive information redacted, as WikiLeaks had been doing.

WikiLeaks blamed the Guardian, the British newspaper with which it had been working, for publishing the password to the hidden document files in a book about WikiLeaks earlier this year. The Guardian responded that it was told when it was given the password that it was temporary, to be changed within a day, purchase Cipro for sale.

In the meantime, as Der Spiegel explained well, Daniel Domscheit-Berg had defected from WikiLeaks with the server that contained the files, and other WikiLeaks supporters spread the files around to keep them from being taken off the web, Purchase Cipro. Once the password leaked out, the contents of the files gradually started spilling online, and by Wednesday night, they were completely public, according to Der Spiegel. It's not entirely clear what WikiLeaks will do with the files now, Cipro duration, but that's where the conflict stands.

—

FT pulls out of the App Store: Back in June, the Financial Times became the first major news organization to develop an HTML5 app for Apple's App Store, allowing it to design a single app for multiple platforms and to handle subscriptions outside of the app itself, which gave it a way around Apple's 30% cut. FT removed the app from the App Store this week instead of complying with Apple's requirement that all subscriptions be handled within apps.

As paidContent's Robert Andrews explained Purchase Cipro, , FT can still make money off of existing iPad app users, but the paper says most of its users have switched over the web app, and its web app use is growing quickly enough that this isn't a big loss anyway. As GigaOM's Darrell Etherington pointed out, this could be an important test case in whether a news organization can replace its Apple-based app business with an HTML5-based web app, comprar en línea Cipro, comprar Cipro baratos.

—

A new generation of campaign reporters: We're starting to hurtle toward full-on presidential campaign season in the U.S., and according to the New York Times, many of the reporters who'll be covering it are 20-somethings, mere babes in the dark, scary woods of campaign journalism. The Times did a trend story on these young reporters, Doses Cipro work, focusing on a boot camp for them put on by CBS and National Journal. Among the advice they're getting: Be careful to slip up in public view, and don't break news on Twitter.

Mocking, of course, ensued, Purchase Cipro. Village Voice's Rosie Gray said CBS and National Journal are asking to get beat on big stories with their Twitter policy, and Alex Pareene of Salon said the moral of the story is that modern campaign journalism is so inane that it can be pushed off to barely experienced reporters without anyone being the wiser. The Columbia Journalism Review's Erika Fry had perhaps the most substantive concern: Why are these reporters being taught primarily about avoiding gaffes, rather than actually doing good journalism.

—

Reading roundup: Here's the rest of what happened in this crazy-busy news week:

— The New York Times' public editor, buy Cipro from canada, Arthur Brisbane, wrote a column criticizing the Times' popular DealBook site for missing large-scale economic issues in favor of small, incremental daily stories. Times business editor Larry Ingrassia fired back with a defense of DealBook, and Reuters financial blogger Felix Salmon also defended DealBook, saying Brisbane was making a false either-or distinction, among other errors. Purchase Cipro, — A few more reflections and analyses of Steve Jobs' impending departure as Apple CEO, announced last week: The New York Times' David Carr on what he changed, and Wired's John C. Abell on Jobs' legacy and Tim Carmody on Jobs and the arts.

— He's made the point before in different ways, but NYU j-prof Jay Rosen's analysis of why the system of political news coverage is broken is still worth a read. He also followed it up with a rethinking of what political journalism could be.

— Finally, NPR's Matt Thompson wrote a great piece on what journalists can learn from the scientific method, tying together some useful big ideas.

September 16th, 2011

Bactrim Dosage

[This review was originally posted at the Nieman Journalism Lab Bactrim Dosage, on Aug. 26, 2011.]

Apple begins life after Jobs: This week in the media and tech world was defined by three men's departures, all announced on Wednesday. By far the biggest was Steve Jobs' resignation as CEO of Apple, 35 years after he founded the company. The decision was largely health-driven, as Jobs was diagnosed with pancreatic cancer in 2004, Bactrim dosage, underwent a liver transplant in 2009, and has been on medical leave since January. Jobs will continue to be Apple's chairman, and as the Wall Street Journal reported, he'll still be involved in product development.

The announcement has drawn a massive amount of commentary, and Techmeme is the best place to gorge yourself on it — or you can read Adam Penenberg's mashup, Bactrim Dosage. Here's a small selection of some of the most interesting stuff, Bactrim canada, mexico, india, starting with the reflections on Jobs' legacy: All Things Digital's Walt Mossberg put together a sharp little rundown of the ways Jobs has changed the computing, animation, music, and mobile media industries. (TV is next.) Tech blogger John Gruber marveled at the company Jobs has built, saying, "Jobs’s greatest creation isn’t any Apple product. It is Apple itself."

Om Malik of GigaOM said Jobs taught us that building the future requires taking the long view, buy Bactrim from mexico, and tech guru Robert Scoble praised Jobs as a CEO who genuinely cared about his products, not just profits. If you're looking for more on Jobs himself, Byliner highlighted seven definitive profiles of the man from the past 15 years. Bactrim Dosage, Jobs' successor is Tim Cook, an Alabaman who joined Apple in 1998 and has been the company's chief operating officer since 2007. Cook has served as interim CEO twice, and he's essentially been acting as CEO throughout Jobs' medical leave this year. My Bactrim experience, Reuters profiled Cook, and All Things Digital's John Paczkowski said that while he's not going to be the visionary leader that Jobs was, he's the steady hand that Apple needs right now. The Atlantic's Nicholas Jackson said that Cook has learned to emulate Jobs as well as anyone could and noted all of the successful launches he's presided over. Wired's Tim Carmody wrote the most thorough defense of Cook as Jobs' successor, detailing his history with the company and his logistics innovations in particular.

The consensus on the Jobs-to-Cook transition seemed to be that Apple is losing a uniquely influential, irreplaceable CEO, but that the company is strong enough to stay well ahead of its competition anyway. Business Insider's Matt Rosoff cataloged what Apple will lose with Jobs, and msnbc.com's Wilson Rothman took stock of where Apple stands as Jobs leaving, suggesting that it might need to start working harder to fight for market share, Bactrim Dosage. Slate's Farhad Manjoo argued that Jobs has set his company up perfectly to continue his success, and Reuters' Felix Salmon predicted this transition will go down as a textbook example of a well-executed succession plan, what is Bactrim. Cook, for his part, assured Apple employees that the company's not going to change.

—

Two media legends leave their posts: The other two men to depart were in the media world: Poynter's pioneering media blogger Jim Romenesko and Slate media critic Jack Shafer. Romenesko, who's been running the definitive blog for news on the journalism business since the late '90s, Bactrim used for, will be semi-retiring in January, occasionally contributing reported media pieces to Poynter and doing some writing on a new personal site. The Huffington Post's Michael Arrington broke the news Bactrim Dosage, , and Romenesko's editor, Julie Moos, explained it from Poynter's perspective, detailing their ongoing transition of Romenesko to a group blog.

Poynter's Bill Mitchell told the story of Romenesko's tenure at Poynter, and touched on some of the enormous influence he's had: He chronicled one of the most important eras in journalism, helped aggregation be seen as a journalistic craft, and "brought transparency to newsrooms, equipping readers and staffers alike to hold those organizations accountable in the way that they scrutinize the operations of others."

The American Journalism Review's Rem Rieder also reflected on Romenesko's impact, and others chimed in on Twitter: Rare Planet's Patrick Thornton said he "showed journalists that good curation is journalism, get Bactrim," and the New York Times' Brian Stelter (who founded TVNewser) and paidContent founder Rafat Ali said he inspired them to start their sites. And while Wired's Tim Carmody called him "Twitter before Twitter," Romenesko himself told the New York Times he found himself disoriented by the rise of social media, saying, "My role kind of vanished."

Shafer was one of four laid off from Slate, where he had written about media since 1996, Japan, craiglist, ebay, overseas, paypal, the year the site was founded. Just hours before the news came down, the American Journalism Review had posted a profile of Shafer, with several luminaries praising his fearlessness and his meticulous research and reporting.

The layoff spurred a lot of confusion and complaints on Twitter and elsewhere, led by AJR's Rem Rieder, who called the decision "befuddling and disappointing." Northeastern j-prof Dan Kennedy also questioned the move, calling Shafer a "dogged reporter in a field where too many media critics would prefer to sit back and pontificate" and praising his iconoclastic perspective in an environment dominated by lockstep liberals and conservatives, fast shipping Bactrim.

Media critic Erik Wemple of the Washington Post said the layoffs weren't so preposterous given the financial struggles of Slate's owner, the Washington Post Co., but Forbes' Jeff Bercovici wondered if Slate's general-interest approach to the web still makes sense, Bactrim Dosage. Hamilton Nolan of Gawker used the occasion to opine on the decline of the media critic. Shafer, meanwhile, talked to Adweek about how he approached his job and what's next for him.

—

What should online identity be?: As Google+ grows, it's also drawing its share of detractors in the tech world, Online buying Bactrim, with various gripes about the new social network. Tech guru Robert Scoble, one of Google+'s heaviest users, also said it won't be ready to go beyond the tech crowd until it finds a way to cut down on the noise. GigaOM's Mathew Ingram echoed that thought and added a complaint about the difficulty of finding new users to connect with. Others are pushing back against that: The Huffington Post's Craig Kannalley said Google+ has all the building blocks Bactrim Dosage, of a successful platform, and MySpace founder Tom Anderson said you'll eventually be using it.

One of the primary complaints about Google+ since its launch has been its real-names policy, and Mathew Ingram continued to beat that drum this week, saying that Google lacks transparency about its motives, suggesting that Google allow any pseudonym users desire but also offer verified identities for users that request it, Bactrim mg.

Web editing veteran Derek Powazek defended Google, arguing that the notion that no one on the web uses their real name is dead: "Outside of a few legitimate edge cases and the occasional sci-fi fantasy, who we are online is simply who we are." Even though there's still a need for a space for anonymous speech online, he said, it's not up to corporations like Google to provide it for us.

The discussion about real names also extended again into the area of comment sections this week, Where can i buy Bactrim online, with Time's Graeme McMillan arguing that Facebook comments make those sections more civil, and the Huffington Post's Mandy Jenkins noting that Facebook comments don't necessarily solve the anonymity problem. Echo's Chris Saad said real names aren't the real issue with comment sections for media companies, and an Ad Age survey found that most online readers don't care about comments.

—

Integrating new media into journalism training: A note from across the pond: In a survey released this week, members of Britain's National Council for the Training of Journalists cast an emphatic vote for traditional media skills over new media expertise when it comes to the group's prestigious National Certification Examination, Bactrim Dosage. (The exam is used as a qualification for newsroom positions, and helps determine pay in some cases.)

Those results upset a number of British journalists who saw them as evidence of a technology-averse media establishment. The Guardian's Martin Belam worried that today's young journalists are being "encouraged to pay for qualifications that will equip them to work in a 90s newsroom, because the people designing the courses and the industry input they receive are all from people who cut their teeth in a 90s newsroom." J-prof Andy Dickinson called the group's desires journalism training for the common denominator, buy no prescription Bactrim online, not the future.

Numerous other journalists — Wales Online's Alison Gow, Reed Business Information's Adam Tinworth, David Higgerson of Trinity Mirror, and American Kerry Northrup — made a similar point: It's a fallacy, they said, Rx free Bactrim, to think of social media, multimedia and web proficiency as separate skills from the classic skills of reporting and storytelling — they're just other platforms on which to apply those skills.

—

Reading roundup: Really, there was other stuff going on this week than important people leaving their jobs. Here's a taste:

— A site called The Daily Dot Bactrim Dosage, launched this week with the goal of being "the web's community newspaper." So what does that mean. It's trying to cover the web's social networks, like Facebook, Twitter, Reddit, cheap Bactrim, and YouTube with reporting like a small-town paper might do. Adweek, Mashable, and VentureBeat have features on it, and one of its founders, Nicholas White, gave some lessons from his experience.

— The long-hated rule known as the Fairness Doctrine was officially taken off the books by the U.S. Federal Communications Communication this week. Mother Jones' Kevin Drum said goodbye.

— A few News Corp. notes: The (News Corp.-owned) Wall Street Journal looked at how the plans to tap the phone of a 13-year-old murder victim went awry at News of the World, the Daily Beast's Brian Cathcart focused on the investigator at the center of that scandal, and the Los Angeles Times' Joe Flint looked at News Corp.'s influence-peddling game here in the U.S.

— Two posts to leave you with: Maria Popova's fantastic post here at the Lab on the new rarity in the information abundance of the web, and some more great advice for journalism students from the Online Journalism Review's Robert Niles.

September 16th, 2011

Cephalexin Price

[This review was originally posted at the Nieman Journalism Lab Cephalexin Price, on Aug. 19, 2011.]

Is social media killing big ideas?: In the New York Times this week, USC fellow Neal Gabler put forward a different form of the familiar "information overload" complaint, this time tying the proliferation of social media to the paucity of big ideas. We don't spend time thinking about and valuing big ideas, Cephalexin from canada, he argued, because we're too busy trying to process — and add to — the flood of information coming at us through social media. You can't think and tweet at the same time, Gabler said, because tweeting "is a form of distraction or anti-thinking."

Naturally, this didn't go over particularly well among the online media punditry. Several people countered that one of Twitter's functions is to direct users to big ideas, no prescription Cephalexin online, to point outside of its 140-character limits through hyperlinks. Media prof Chuck Tryon, author Stephen Baker, and Techdirt's Mike Masnick all made that argument, with Masnick summing it up well: "While social media may not have enlarged Gabler's intellectual universe, it has massively enlarged mine, Cephalexin Price. Thanks to Twitter specifically, I've been able to meet tons of fascinatingly smart people I never would have met otherwise." The trick, as Baker said, is to "listen to the right people, Cephalexin interactions, and then follow their links."

Two other writers made particularly smart points: Kevin Drum of Mother Jones noted that where before we knew exactly where to find big ideas and how to discuss them, we're now in the middle of a massive media transition. That doesn't mean the big idea is dead, he said, it means it's headed somewhere new, and we don't know exactly where yet. And the Lab's Megan Garber pointed out that Gabler's vision of big ideas is closely tied to big media, buy Cephalexin online cod, but argued that those big ideas don't need big media to thrive. Instead, she said, "Increasingly, though, Cephalexin australia, uk, us, usa, the ideas that spark progress are collective, diffusive endeavors rather than the result (to the extent they ever were) of individual inspiration."

—

A paywall plan that understands online readers?: Reuters blogger Felix Salmon is already on record as a supporter of the New York Times' five-month-old paywall, and this week he detailed exactly why he thinks it's so effective. Cephalexin Price, Salmon likened the Times' metered model, with all of its leeway and potential workarounds, to a polite "Please keep off the grass" sign. He argued that contra the prevailing philosophy that readers won't pay for something they can get for free, the Times is betting that "the pleasure of reading its content will be enough to persuade a large number of people to pay. It’s a far more attractive model, and one which is much more likely to attract new young subscribers over the long term."

In a follow-up post, buy cheap Cephalexin, Salmon explained why the Times' model is fundamentally different from the Financial Times' pay meter — it's not trying nearly as hard to keep non-subscribers away from its content. Venture capitalist Fred Wilson and Poynter's Jeff Sonderman agreed with Salmon's premise: Wilson praised the efficacy of getting paid after the fact rather than before, and Sonderman said the Times has discovered that convenience, duty, and appreciation are more compelling motivations than coercion. Cephalexin over the counter, There was one notable dissenter: GigaOM's Mathew Ingram, who took issue with the idea that the Times' plan has been successful, arguing instead that it's not growing the paper's online audience, but setting up digital sandbags to protect a declining print product. The plan "has virtually nothing to do with actually taking advantage of the digital world in any concrete way," Ingram wrote, Cephalexin Price. "It’s just charging people nickels and dimes for their paper, the way the NYT and other newspapers have for a century and a half or so."

—

News Corp.'s problems continue to grow: The damning information against News Corp. in the phone-hacking scandal at its former News of the World newspaper keeps on coming, Cephalexin no rx. This week, it was a four-year-old letter written by Clive Goodman, a reporter at the center of the scandal. In it, Goodman said that the hacking was discussed regularly at the paper and suggested that knowledge of it ran much deeper than News Corp. Cephalexin Price, has been insisting. Ordering Cephalexin online, Notably, News Corp. had submitted the letter to Parliament but redacted the incriminating parts.

With the new revelation, Slate's Jack Shafer wrote that "the scandal has grown too large for one or two willing Murdoch lieutenants or employees to stanch it by taking the fall." That impression has led many watchers to wonder, as the Guardian's Brian Cathcart did, if James Murdoch, Cephalexin recreational, Rupert's son, may be forced to resign. James responded late last week to Parliament's questions about his truthfulness in his testimony to them last month, and News Corp. is reportedly making plans in case he decides to step aside, Cephalexin Price.

The bad news continues to pile up elsewhere in News Corp., Cephalexin photos, too. The private investigator at the center of the scandal sued News International (the company's British newspaper division) for not paying his legal bills, and officially acknowledged in its annual report that the scandal could impair its business, and that it doesn't know how much money it'll end up costing. Two more commentators — the New Yorker's Ken Auletta and Reuters' David Callahan — echoed a popular sentiment lately, saying the responsibility for this whole ordeal lies directly with Rupert Murdoch.

—

Google grabs a mobile-phone producer: For the tech geeks among us, buy Cephalexin online no prescription, Google made some big news this week, buying Motorola Mobility, Motorola's mobile devices division, for $12.5 billion. According to the New York Times Cephalexin Price, , the deal had a lot to do with stockpiling patents in order to defend its Android mobile operating system from patent lawsuits. It also may allow Google to drive down development costs for the all-important smartphone and tablet markets. Order Cephalexin online c.o.d, Cory Bergman of Lost Remote noted that this move isn't just about mobile, though — it also represents Google's biggest move into TV yet. With Motorola's significant share of the cable-TV hardware business, Bergman said, Google now has the opportunity to seamlessly integrate its technology with TVs across the world.

Here at the Lab, Joshua Benton used the acquisition as an example of the tension between a Windows-style modular approach to business, buy Cephalexin without a prescription, with products that can be swapped in and out, and an Apple-esque interdependent one, with a set of interlinking, proprietary products. He also applied the idea to news, saying our journalistic ecosystem needs both the more open modular approach and the more packaged interdependent approach, Cephalexin Price.

A couple of other posts looked at the story of the deal itself: Reuters' Felix Salmon examined the decline (and declining value) of the financial scoops beat, Cephalexin schedule, and Gawker's Ryan Tate saw Google's manufactured press-release quotes by its business partners as a sign that Google is moving away from the "Don't Be Evil" mantra toward being a tight-fisted corporate giant.

—

Reading roundup: This week was a pretty packed one. Here's the best of the rest:

— This week in AOL: The New York Times' Verne Kopytoff analyzed why the new-look AOL has experienced so many hiccups, and j-prof Dan Kennedy seized on the tidbit in that article that AOL would reportedly be profitable without Patch.

— Web philosopher David Weinberger wrote a fantastic piece about the journalistic curiosity and community exchange that's present at Reddit, and GigaOM's Mathew Ingram echoed his thoughts.

— The Knight Digital Media Center's Joy Mayer has apparently become journalism's "Minister of Engagement," and she's earned the title, publishing a thorough guide to community engagement for newsrooms.

— The Online Journalism Review's Robert Niles wondered what journalism is worth, and came up with some depressing answers.

— Finally, since classes are starting up all over the place in the next week or two, here's 10 great tips for journalism students from Sarah Marshall of Journalism.co.uk, via Twitter.

August 13th, 2011

Buy Retin A No Prescription

[This review was originally posted at the Nieman Journalism Lab Buy Retin A No Prescription, on Aug. 12, 2011.]

Murdoch passes Wall Street's test: The fallout from News Corp.'s phone hacking scandal continued to spread this week, with the reported arrest of another former News of the World editor and the report that the ostensibly fired News Corp. British chief, Rebekah Brooks, Retin A alternatives, is still on the company payroll.

Three weeks after testifying before Parliament, Rupert Murdoch faced Wall Street analysts this week in a conference call, telling them that he's not going anywhere and that the scandal hasn't done any material damage to the company outside of News of the World. Purchase Retin A, All Things Digital's Peter Kafka said Wall Street really doesn't care about the hacking, and Murdoch didn't say much about the few questions he did get on it.

Murdoch also had to meet with News Corp.'s board, but as the New York Times' Jeremy Peters reported, the board's officially independent members include numerous people who have deep personal ties to Murdoch, Buy Retin A No Prescription. Perhaps more troubling was a different connection among one of the board members: According to Time's Massimo Calabresi, one of them is "best friends" with the district attorney leading the U.S. investigation into the company.

The Times' David Carr uncovered more hints at News Corp.'s enormous political influence here in the States, Retin A pics, detailing cases of swift approval of a merger by a Justice Department unit led by a future News Corp. executive, as well as a suspiciously dropped federal criminal case. "The company’s size and might give it a soft, less obvious power that it has been able to project to remarkable effect, Buy Retin A without prescription, " Carr concluded. Buy Retin A No Prescription, At Adweek, Murdoch biographer Michael Wolff went further, reporting that the Justice Department is considering investigating News Corp. on racketeering charges, though Forbes' Jeff Bercovici doubted that would happen. For a bit more info on the situation, here's a good Q&A with Nick Davies, the Guardian reporter who's been all over the story, order Retin A no prescription.

—

AOL's slap from investors: This week hasn't been a good one for AOL: After it reported a quarterly loss on Tuesday, its stock dropped by about a quarter by the end of the day. All Things Digital's Peter Kafka gave a quick explainer of why investors are so down on AOL: What little money they're making isn't coming from the all-important display advertising business. Mathew Ingram of GigaOM added more depth to that analysis, arguing that investors are doubting AOL's assurances that its two big gambles — Patch and the acquisition of the Huffington Post — will pay off, Buy Retin A No Prescription.

According to AOL CEO Tim Armstrong (paraphrased by Business Insider), Retin A price, coupon, the reason for those problems is that AOL's advertising side hasn't scaled well enough. Peter Kafka explained that AOL's advertising (especially display) is indeed up, though much of that can be attributed to the HuffPo and TechCrunch acquisitions. Forbes' Jeff Bercovici said AOL's public image problem has even damaged the previously successful HuffPo, quoting an analyst who called AOL a "dead brand." Wired's Tim Carmody decided to unite our two big stories this week and suggested that AOL would be a perfect fit for a purchase by News Corp.

Meanwhile's AOL's local-news initiative, Retin A samples, Patch, launched a Groupon-esque daily deal service, and Iowa grad student Robert Gutsche Jr.questioned Patch's standards for separating journalism and advertising — and got the runaround from Patch when he asked them about it. AOL's new daily tablet magazine, Editions, Buying Retin A online over the counter, also drew some criticism, with Fast Company's Austin Carr perturbed that it's not AOL-y enough.

—

A news org gets into tablets Buy Retin A No Prescription, : We've already seen numerous challengers to the iPad's early stranglehold on the tablet marketplace, but the Tribune Co. might be the first news company to try one out. CNN's Mark Milian reported that the newspaper chain is working on an Android-based tablet, which it's planning on offering it for free or very cheap to people who sign up for extended newspaper subscriptions. It's already missed a mid-August deadline for testing the tablet out, purchase Retin A online.

Media pundits didn't think much of the Tribune's idea. Wired's Tim Carmody urged the Tribune (and media companies in general) to quit developing tablets, arguing that it's way too hard to do if you're a major development company, let alone a news organization. "If major publishers are seriously prepared to blow up their primary revenue stream — print advertising — and slap together a giveaway tablet in order to save money on ink, God help them," he wrote, Buy Retin A No Prescription.

Others echoed Carmody's arguments: PaidContent's Tom Crazit called the project "a colossal waste of money for a company trying to emerge from bankruptcy." Chris Velazco of TechCrunch said the cheap-tablet model (also being talked about by Philadelphia Newspapers) isn't viable. Gizmodo's Brent Rose was less restrained: "WHY??" Morris Communications' Steve Yelvington was a little kinder to the Tribune, saying the numbers might add up, Kjøpe Retin A på nett, köpa Retin A online, but the devil's in the details.

—

The Times gets experimental: The New York Times has frequently made strong pushes into news innovation over the past several years, and this week it started another one, launching a new public test kitchen for projects in development. The Lab's Megan Garber explained what the site, beta620, Retin A for sale, is all about, but GigaOM's Mathew Ingram, while applauding the effort, expressed some doubt about whether the Times is really capable of developing a startup's mindset. Buy Retin A No Prescription, Tim Carmody of Wired, on the other hand, said the startup analogy isn't the right one for the Times. Retin A online cod, With these projects, he said, "The New York Times has become an openly experimental public institution. It’s less a cathedral consecrated to its own past than a free museum where patrons are invited to touch and transform everything they see." Poynter's Jeff Sonderman had some suggestions for next steps for the Times to take with beta620: experimenting with design, getting away from the long narrative article, and rethinking comments, Retin A trusted pharmacy reviews.

—

The real-name debate: One long-simmering debate I want to briefly catch you up on: Google+ has decided to take the Facebook route of disallowing pseudonyms, adjusting but reaffirming its policy in the face of online criticism late last month and again on Thursday. The outcry continued, voiced most prominently late last week by social media researcher danah boyd, Order Retin A from mexican pharmacy, who asserted that "'real names' policies aren’t empowering; they’re an authoritarian assertion of power over vulnerable people."

Liz Gannes of All Things Digital said she understands Google's motivations for enforcing real names and unifying everything under its umbrella within the same identity, but the idea of doing the latter is awkward at best and frightening at worst. The Atlantic's Alexis Madrigal, meanwhile, announced he's changed his mind against real-name policies, arguing that requiring real names online is a radical departure from the relationship between speech and identity in the offline world, Buy Retin A No Prescription.

—

Reading roundup: A few other things to keep an eye on this week:

— Amazon released a version of its Kindle app for browsers, called the Kindle Cloud Reader. GigaOM's Mathew Ingram said the browser-based e-book app (which bypasses Apple's restrictions) could be a roadmap for the future of the web, but Wired's Tim Carmody said it still doesn't get the web, Retin A without prescription.

— Google announced it's making its hand-chosen Editors' Picks a standing feature on Google News. The Lab's Megan Garber explained what Google's doing with it. Buy Retin A No Prescription, Meanwhile, James Gleick at The New York Review of Books offered a thoughtful piece on Google's domination of our online lives.

— Adweek explained an underrated obstacle to innovation and progress in news organizations' online efforts: the intractable CMS.

— Steve Buttry, now with the Journal Register Co., gave his lessons from TBD's demise on the Washington local news site's first birthday. It's short but solid. Enjoy.

August 13th, 2011

Flagyl Mg

[This review was originally posted at the Nieman Journalism Lab Flagyl Mg, on Aug. 5, 2011.]

How right do we need to be on Twitter?: It's not particularly uncommon for false information to spread on Twitter under the guise of breaking news, and that's what happened late last week, when several journalists spread the rumor that CNN's Piers Morgan had been suspended from his show as part of the fallout from News Corp.'s phone hacking scandal, which turned out to be untrue. Flagyl description, This misinformation, however, led to the most interesting discussion on Twitter and accuracy we've seen in a while.

It started with Reuters' Felix Salmon, one of those who tweeted the Morgan rumor, defending the practice of quickly tweeting breaking news (false, in some cases) and then quickly correcting it, is Flagyl safe. "Twitter is more like a newsroom than a newspaper: it’s where you see news take shape. Rumors appear and die; stories come into focus; people talk about what’s true and what’s false," he wrote. While news organizations' official accounts should stick to confirmed reports, individual reporters should be able to tweet unconfirmed information, Salmon said, as long as they attribute it properly and correct it quickly, Flagyl Mg.

Several writers objected to this line of reasoning: Fishbowl NY's Chris O'Shea said Salmon should be committed to tweeting true information because the fact that he's seen as a credible news source is the reason people follow him on Twitter in the first place. The Columbia Journalism Review's Dean Starkman countered that Twitter is much closer to publishing than a newsroom meeting: "The reason people feel a bit of embarrassment after making a mistake on Twitter is precisely because it’s so public." And Rem Rieder of the American Journalism Review said Salmon's strategy constitutes a reckless disregard for reporters' individual brand and reputation.

Others were more sympathetic to Salmon's point. Mathew Ingram of GigaOM pushed back against Rieder, Flagyl no prescription, arguing that news is a process, not just the publication of a finished product, and Twitter is part of that process. Salmon's editor at Reuters Flagyl Mg, , Anthony DeRosa, who also tweeted the Morgan rumor, agreed with Salmon that Twitter is a newsroom, but vowed to be more careful to tweet verified information. The Journal Register Co.'s Steve Buttry, meanwhile, said that the dichotomy between being first and being right is a false one for journalists — and that journalists should strive for both.

—

A new tool for the new newsroom: Chartbeat, taking Flagyl, which does real-time analytics for websites, launched a news-oriented version of its tool last week called Newsbeat. Poynter's Jeff Sonderman put together a good overview of the service, which includes more detail about traffic trends and sources than Chartbeat. In an interview with GigaOM's Mathew Ingram, Discount Flagyl, Chartbeat's Tony Haile answered the objection that this type of data will just lead to a "tyranny of the popular," arguing instead that the service may instead show journalists how they're underestimating their audiences, or how they can repackage news stories to make them more understandable to readers.

The Atlantic's Alexis Madrigal provided an example from his own experience, noting that Chartbeat has shown that a surprising number of offbeat longform stories there generate big traffic, Flagyl Mg. Newsbeat, he said, could help the mass of news sources fighting for attention online each find their sweet spot. "I love analytics because I owe them my ability to write weird stories on the Internet, where can i find Flagyl online," he said.

At Wired, Tim Carmody emphasized the real-time nature of the information, noting that the need for that kind of information is growing as news organizations are increasingly editing and publishing in real time, too. Order Flagyl from United States pharmacy, Here at the Lab, Megan Garber was intrigued by the fact that Newsbeat offers individualized dashboards for each writer and editor's content. Flagyl Mg, The feature, she reasoned, demonstrates the increased encouragement of entrepreneurialism within the modern newsroom: "Increasingly, the gates of production are swinging open to journalists throughout, if not fully across, the newsroom. That’s a good thing. It’s also a big thing. And Newsbeat is reflecting it."

—

A truly daily tablet publication: Seems almost every other week we have a new entry into the tablet news market; this week it's AOL, which launched its daily tablet magazine Editions this week. All Things Digital and Poynter have good overviews of what the new publication is: Notably, generic Flagyl, it's delivered to your tablet just once a day (at the time of your choosing), with a set ending page, and without any updates. It's big on personalization, tailoring news to each user a bit like Pandora, and it also includes some local news and, as Poynter noted, primarily aims to recreate the print experience (a fake mailing label, even!), Flagyl Mg.

To the people behind Editions, its lack of updates and finite, Flagyl results, print-like interface are assets: As one of them told the New York Times, "For a lot of people, [continual updating] becomes oppressive. This is not tapping you on the shoulder all the time." But at TechCrunch (which is also owned by AOL), Erick Schonfeld was skeptical, asserting that if he feels like he's getting day-old news on Editions, he'll just stick to the web, online buying Flagyl hcl. "News apps need to be as current as the Web. Those are just table stakes," he wrote. Mashable's Lauren Indvik, on the other hand, was rather impressed, Flagyl without a prescription, saying the finiteness of the magazine provides a nice contrast to the unruliness of the web.

—

The scandal goes stateside Flagyl Mg, : A couple of updates on the News Corp. phone hacking scandal: The story is beginning to migrate across the Atlantic, as attention begins to shift toward several accusations of spying made years ago against News Corp. holdings in the United States. Nick Davies, where can i buy cheapest Flagyl online, the Guardian reporter who broke this story open earlier this summer, was reportedly in the States this week investigating News Corp. At New York magazine, Frank Rich urged Americans to look more closely into Murdoch's behavior here: "We’ve become so inured to Murdoch tactics over the years—and so many people in public life have been frightened, silenced, Flagyl forum, co-opted, or even seduced by them—that we have minimized his impact exactly the way his publicists hoped we would, downgrading News Corp. misbehavior merely to tabloid vulgarity and right-wing attack-dog politics."

Two other notes: The News Corp.-owned Wall Street Journal is surveying subscribers about its image in light of the phone hacking scandal, and the American Journalism Review's John Morton said that for all his faults, Rupert Murdoch's heart is in newspapers, something he appreciates, Flagyl Mg.

—

Reading roundup: Several things journalists and educators might find useful this week:

— Some smaller papers in the Lee Enterprises chain are going to be trying out metered-model online pay plans, which include a small charge for the website even for print subscribers. Poynter's Rick Edmonds explained why. And at the Lab, buy generic Flagyl, Ken Doctor looked at how the economics of circulation and advertising are moving online.

— There are still a few places where print is still king — among the wealthy, for instance, as data from this Ad Age survey show.

— A few great how-to's and suggestions: Journalism.co.uk's SEO primer for journalists; Florida j-prof Mindy McAdams' six proposals for journalism education; and a quick guide to data journalism from the Guardian. Flagyl dangers, — Finally, media analyst Alan Mutter made a strong case for why newspapers' business model will never stabilize and urged them to begin "intelligently, and speedily, de-stabilizing their enterprises." It's a case that's been made many times before, but one that probably needs to be heard again.

Mark Coddington

Associate Professor, Washington and Lee University

this week

Purchase Cipro

Bactrim Dosage

Cephalexin Price

Buy Retin A No Prescription

Flagyl Mg